I-MAB
(FRA:0VY)
€
1.06
0 (0%)
Market Cap: 85.73 Mil
Enterprise Value: -183.04 Mil
PE Ratio: 0
PB Ratio: 0.41
GF Score: 34/100 I-MAB (FRA:0VY) Transcripts
- I-Mab at Jefferies London Healthcare Conference TranscriptNov 14, 2023
- Half Year 2023 I-Mab Earnings Call TranscriptAug 17, 2023€2.14 (-0.93%)Earnings
- Full Year 2022 I-Mab Earnings Call TranscriptMar 31, 2023€3.2 (+3.90%)Earnings
- I-Mab Phase 2 Clinical Data of CD47 Antibody Lemzoparlimab Call TranscriptSep 12, 2022
- Half Year 2022 I-Mab Earnings Call TranscriptAug 30, 2022€5.8 (-2.52%)Earnings
- I-Mab R&D Day TranscriptJul 20, 2022
- I-Mab TJD5 Phase 2 Clinical Trial Data Update Call TranscriptMay 27, 2022
- Full Year 2021 I-Mab Earnings Call TranscriptMar 29, 2022€15.3 (-4.97%)Earnings
- I-Mab at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- I-Mab Corporate Call TranscriptDec 21, 2021
- I-Mab Most Recent Clinical Data Update Conference Call -- English Session TranscriptDec 14, 2021
- I-Mab and Jumpcan To Announce its Strategic Commercial Partnership on Eftansomatropin Alfa - Special Call TranscriptNov 10, 2021
- Half Year 2021 I-Mab Earnings & Corporate Progress Update Conference Call TranscriptAug 31, 2021
- I-Mab to Discuss Phase 1 Data on Highly Differentiated CD73 Antibody Uliledlimab at ASCO 2021 Call TranscriptJun 07, 2021
- I-Mab at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- I-Mab Corporate Analyst Meeting TranscriptApr 26, 2021
- Full Year 2020 I-Mab Earnings Call TranscriptMar 29, 2021€39.4 (-1.50%)Earnings
- IMAB Lemzoparlimab Phase 1 Clinical Trial Data Update Conference Call TranscriptNov 13, 2020
- I-Mab SITC Data Conference Call TranscriptNov 09, 2020
- I-Mab Company Update Conference Call TranscriptSep 04, 2020
- Half Year 2020 I-Mab Earnings Call TranscriptAug 31, 2020€26.2 (+0.77%)Earnings
- I-Mab Update Conference Call TranscriptMay 28, 2020
- I-Mab at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Full Year 2019 I-Mab Earnings Call TranscriptMar 31, 2020Earnings
- 1